178 related articles for article (PubMed ID: 23685547)
1. Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat.
Hanson GR; Hoonakker AJ; Robson CM; McFadden LM; Frankel PS; Alburges ME
J Pharmacol Exp Ther; 2013 Aug; 346(2):173-81. PubMed ID: 23685547
[TBL] [Abstract][Full Text] [Related]
2. Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia.
Frankel PS; Hoonakker AJ; Alburges ME; McDougall JW; McFadden LM; Fleckenstein AE; Hanson GR
J Pharmacol Exp Ther; 2011 Mar; 336(3):809-15. PubMed ID: 21131268
[TBL] [Abstract][Full Text] [Related]
3. Response of limbic neurotensin systems to methamphetamine self-administration.
Hanson GR; Hoonakker AJ; Alburges ME; McFadden LM; Robson CM; Frankel PS
Neuroscience; 2012 Feb; 203():99-107. PubMed ID: 22245499
[TBL] [Abstract][Full Text] [Related]
4. Differential response of neurotensin to methamphetamine self-administration.
Frankel PS; Hoonakker AJ; Hanson GR
Ann N Y Acad Sci; 2008 Oct; 1139():112-7. PubMed ID: 18991855
[TBL] [Abstract][Full Text] [Related]
5. Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
Psychopharmacology (Berl); 2014 Aug; 231(15):2933-40. PubMed ID: 24522333
[TBL] [Abstract][Full Text] [Related]
6. Mephedrone alters basal ganglia and limbic neurotensin systems.
German CL; Hoonakker AH; Fleckenstein AE; Hanson GR
J Neurochem; 2014 Aug; 130(3):402-7. PubMed ID: 24678634
[TBL] [Abstract][Full Text] [Related]
7. Effect of low doses of methamphetamine on rat limbic-related neurotensin systems.
Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
Synapse; 2015 Aug; 69(8):396-404. PubMed ID: 25963809
[TBL] [Abstract][Full Text] [Related]
8. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
McCormick SE; Stoessl AJ
Neuroscience; 2003; 119(2):547-55. PubMed ID: 12770567
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of Neurotensin Receptors in the Ventral Tegmental Area Decreases Methamphetamine Self-Administration and Methamphetamine Seeking in Mice.
Dominguez-Lopez S; Piccart E; Lynch WB; Wollet MB; Sharpe AL; Beckstead MJ
Int J Neuropsychopharmacol; 2018 Apr; 21(4):361-370. PubMed ID: 29272412
[TBL] [Abstract][Full Text] [Related]
10. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.
Boules M; Iversen I; Oliveros A; Shaw A; Williams K; Robinson J; Fredrickson P; Richelson E
Brain Res; 2007 Jan; 1127(1):90-8. PubMed ID: 17113052
[TBL] [Abstract][Full Text] [Related]
11. Systemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedation.
Sharpe AL; Varela E; Beckstead MJ
PLoS One; 2017; 12(7):e0180710. PubMed ID: 28686721
[TBL] [Abstract][Full Text] [Related]
12. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
Chapman DE; Hanson GR; Kesner RP; Keefe KA
J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
[TBL] [Abstract][Full Text] [Related]
13. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.
Alburges ME; Hoonakker AJ; Horner KA; Fleckenstein AE; Hanson GR
J Neurochem; 2011 May; 117(3):470-8. PubMed ID: 21323925
[TBL] [Abstract][Full Text] [Related]
14. Intra-accumbens shell injections of SR48692 enhanced cocaine self-administration intake in rats exposed to an environmentally-elicited reinstatement paradigm.
Ramos-Ortolaza DL; Negrón A; Cruz D; Falcón E; Iturbe MC; Cajigas MH; Maldonado-Vlaar CS
Brain Res; 2009 Jul; 1280():124-36. PubMed ID: 19442653
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.
Díaz-Cabiale Z; Fuxe K; Narváez JA; Finetti S; Antonelli T; Tanganelli S; Ferraro L
Neuroreport; 2002 May; 13(6):763-6. PubMed ID: 11997683
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological activation of the neurotensin receptor 1 abrogates the methamphetamine-induced striatal apoptosis in the mouse brain.
Liu Q; Hazan A; Grinman E; Angulo JA
Brain Res; 2017 Mar; 1659():148-155. PubMed ID: 28130052
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
18. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A
Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308
[TBL] [Abstract][Full Text] [Related]
19. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
20. Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats.
Baracz SJ; Everett NA; McGregor IS; Cornish JL
Addict Biol; 2016 Mar; 21(2):316-25. PubMed ID: 25399704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
